newsfilter
← Latest News
GlobeNewswire·

Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer

Prior data provide clinical proof-of-concept for narazaciclib's mechanism of action in endometrial cancer Preliminary data from trial's Phase 1 portion expected in 4Q 2023 NEWTOWN, Pa., May 11, 2023 (GLOBE NEWSWIRE)